Method of use of an embolic implant for radio-ablative treatment

US9694201B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9694201-B2
Application numberUS-201414261285-A
CountryUS
Kind codeB2
Filing dateApr 24, 2014
Priority dateApr 24, 2014
Publication dateJul 4, 2017
Grant dateJul 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of radio-ablation in conjunction with embolic implants used for pre-embolization of branch arteries in radio-ablation of the liver or other diseased tissue.

First claim

Opening claim text (preview).

We claim: 1. A method for radio-ablation of a diseased region of tissue within a body of a patient, where said diseased region is proximate healthy tissue or organs, wherein said diseased region and healthy tissue are supplied with blood through vasculature of the patient, and the diseased tissue is supplied with blood through a main artery, and said healthy tissue or organs is supplied with blood through a branch artery of the main artery, said method comprising: implanting an embolic implant in the vasculature at a site proximal to the diseased region, the embolic implant comprising a wire-frame structure having a membrane covering at least one end of the wire-frame structure, wherein the membrane covering the at least one end of the wire-frame structure substantially blocks blood from flowing through the at least one end of the wire-frame structure in a direction of blood flow through the vasculature when the implant is deployed in the vasculature; and depositing a bolus of radio-ablative particles in the main artery distal to the embolic implant site. 2. The method of claim 1 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the branch artery before depositing the bolus of radio-ablative particles, wherein substantially complete occlusion of the branch artery and substantially complete stoppage of blood flow in the branch artery is achieved in less than 5 minutes from implantation of the embolic implant in the branch artery. 3. The method of claim 1 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the branch artery after depositing the bolus of radio-ablative particles. 4. The method of claim 1 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the main artery, distal to the branch artery, before depositing the bolus of radio-ablative particles, the method further comprising: navigating a catheter into the main artery, and navigating a distal segment of the catheter past the embolic implant; delivering the bolus of radio-ablative particles through the catheter to deposit the bolus distal to the embolic implant; and withdrawing the catheter from the main artery. 5. The method of claim 4 further comprising the step of: removing the embolic implant from the main artery after deposition of the bolus. 6. The method of claim 1 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the main artery, distal to the branch artery, after depositing the bolus of radio-ablative particles. 7. The method of claim 1 wherein the wire-frame structure comprises: a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements, said V-shaped elements defining proximal or distal vertices pointing proximally or distally away from a center of the wire-frame structure; and a plurality of longitudinally oriented struts extending from the proximally or distally pointing vertices of the V-shaped elements, said longitudinally oriented struts being joined together near a radial center of the wire-frame structure at the at least one end of the embolic implant, wherein the wire-frame structure is formed of a self-expanding material. 8. The method of claim 1 wherein the embolic implant includes a proximal end and a distal end, the wire-frame structure comprising: a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements via short longitudinally aligned struts to form a central portion of the wire-frame structure, said short struts being longitudinally displaced from each other, said V-shaped elements defining proximal or distal vertices pointing proximally or distally away from a center of the wire-frame structure; a plurality of longitudinally oriented struts extending from the proximally pointing vertices of the shaped elements, said longitudinally oriented struts being joined together near a radial center of the wire-frame structure at the proximal end of the embolic implant, wherein the wire-frame structure is formed of a self-expanding material; and the membrane disposed over the proximal end of the embolic implant, said membrane having a proximal facing surface, said membrane being impermeable to blood on the proximal facing surface. 9. A method for radio-ablative treatment of a liver of a patient, wherein the liver is proximate at least one other organ, wherein the liver and the at least one other organ are supplied with blood through vasculature of the patient, and the liver is supplied with blood through a hepatic artery, and the at least one other organ is supplied with blood through an extra-hepatic branch artery of the hepatic artery, said method comprising: implanting an embolic implant in the vasculature of the patient at a site proximal to the liver of the patient, the embolic implant comprising a wire-frame structure having a membrane covering at least one end of the wire-frame structure, wherein the membrane covering the at least one end of the wire-frame structure substantially blocks blood from flowing through the at least one end of the wire-frame structure in a direction of blood flow through the vasculature when the implant is deployed in the vasculature; and depositing a bolus of radio-ablative particles in the hepatic artery distal to the embolic implant site. 10. The method of claim 9 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the extra-hepatic branch artery before depositing the bolus of radio-ablative particles, wherein substantially complete occlusion of the extra-hepatic branch artery and substantially complete stoppage of blood flow in the extra-hepatic branch artery, is achieved in less than 5 minutes from implantation of the embolic implant in the extra-hepatic branch artery. 11. The method of claim 9 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the extra-hepatic branch artery after depositing the bolus of radio-ablative particles. 12. The method of claim 9 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the hepatic artery, distal to the extra-hepatic branch artery, before depositing the bolus of radio-ablative particles, the method further comprising: navigating a catheter into the hepatic artery, and navigating a distal segment of the catheter past the embolic implant; delivering the bolus of radio-ablative particles through the catheter to deposit the bolus distal to the embolic implant; and withdrawing the catheter from the hepatic artery. 13. The method of claim 12 further comprising the step of: removing the embolic implant from the hepatic artery after deposition of the bolus. 14. The method of claim 9 wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the hepatic artery, distal to the extra-hepatic branch artery after depositing the bolus of radio-ablative particles. 15. The method of claim 9 wherein the wire-frame structure comprises: a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements, said V-shaped elements defining proximal or distal vertices pointing proximally or distally away from a center of the wire-frame structure; and a pl

Assignees

Inventors

Classifications

  • Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body (eye surgery A61F9/007; ear surgery A61F11/00) · CPC title

  • Ablation · CPC title

  • Enhancing the effect of the particle by an injected agent or implanted device · CPC title

  • in a blood vessel · CPC title

  • Surgical glue applicators · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9694201B2 cover?
A method of radio-ablation in conjunction with embolic implants used for pre-embolization of branch arteries in radio-ablation of the liver or other diseased tissue.
Who is the assignee on this patent?
Covidien Lp
What technology area does this patent fall under?
Primary CPC classification A61N5/1002. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).